Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease.

PURPOSE To devise a comprehensive multiplatform genetic testing strategy for inherited retinal disease and to describe its performance in 1000 consecutive families seen by a single clinician. DESIGN Retrospective series. PARTICIPANTS One thousand consecutive families seen by a single clinician. METHODS The clinical records of all patients seen by a single retina specialist between January 2010 and June 2016 were reviewed, and all patients who met the clinical criteria for a diagnosis of inherited retinal disease were included in the study. Each patient was assigned to 1 of 62 diagnostic categories, and this clinical diagnosis was used to define the scope and order of the molecular investigations that were performed. The number of nucleotides evaluated in a given subject ranged from 2 to nearly 900 000. MAIN OUTCOME MEASURES Sensitivity and false genotype rate. RESULTS Disease-causing genotypes were identified in 760 families (76%). These genotypes were distributed across 104 different genes. More than 75% of these 104 genes have coding sequences small enough to be packaged efficiently into an adeno-associated virus. Mutations in ABCA4 were the most common cause of disease in this cohort (173 families), whereas mutations in 80 genes caused disease in 5 or fewer families (i.e., 0.5% or less). Disease-causing genotypes were identified in 576 of the families without next-generation sequencing (NGS). This included 23 families with mutations in the repetitive region of RPGR exon 15 that would have been missed by NGS. Whole-exome sequencing of the remaining 424 families revealed mutations in an additional 182 families, and whole-genome sequencing of 4 of the remaining 242 families revealed 2 additional genotypes that were invisible by the other methods. Performing the testing in a clinically focused tiered fashion would be 6.1% more sensitive and 17.7% less expensive and would have a significantly lower average false genotype rate than using whole-exome sequencing to assess more than 300 genes in all patients (7.1% vs. 128%; P < 0.001). CONCLUSIONS Genetic testing for inherited retinal disease is now more than 75% sensitive. A clinically directed tiered testing strategy can increase sensitivity and improve statistical significance without increasing cost.

[1]  T. Meitinger,et al.  Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. , 2006, American journal of human genetics.

[2]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[3]  Adam P. DeLuca,et al.  North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13. , 2016, Ophthalmology.

[4]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[5]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[6]  A. Ciccodicola,et al.  Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa , 2000, Nature Genetics.

[7]  Mahdi Sarmady,et al.  mtDNA Variation and Analysis Using Mitomap and Mitomaster , 2013, Current protocols in bioinformatics.

[8]  Menachem Fromer,et al.  Using XHMM Software to Detect Copy Number Variation in Whole‐Exome Sequencing Data , 2014, Current protocols in human genetics.

[9]  C Summers,et al.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.

[10]  T. P. Dryja,et al.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma , 1983, Nature.

[11]  Jennifer Doudna,et al.  RNA-programmed genome editing in human cells , 2013, eLife.

[12]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[13]  F. Cremers,et al.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial , 2014, The Lancet.

[14]  Daniele Merico,et al.  Compound heterozygous mutations in the noncoding RNU4ATAC cause Roifman Syndrome by disrupting minor intron splicing , 2015, Nature Communications.

[15]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[16]  E. Stone.  Finding and interpreting genetic variations that are important to ophthalmologists. , 2003, Transactions of the American Ophthalmological Society.

[17]  J. Maassen,et al.  Maternally inherited diabetes and deafness (MIDD): A distinct subtype of diabetes associated with a mitochondrial tRNALeu(UUR) gene point mutation , 1995, Muscle & nerve. Supplement.

[18]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[19]  Adam P. DeLuca,et al.  Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa , 2011, Proceedings of the National Academy of Sciences.

[20]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[21]  T. Aleman,et al.  Reduced-illuminance autofluorescence imaging in ABCA4-associated retinal degenerations. , 2007, Journal of the Optical Society of America. A, Optics, image science, and vision.

[22]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[23]  I. Constable,et al.  Gene Therapy for Age-Related Macular Degeneration , 2016, Asia-Pacific journal of ophthalmology.

[24]  Allison E. Songstad,et al.  Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases , 2015, Progress in Retinal and Eye Research.

[25]  David W. Yandell,et al.  A point mutation of the rhodopsin gene in one form of retinitis pigmentosa , 1990, Nature.

[26]  Adam P. DeLuca,et al.  cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness , 2016, Scientific Reports.

[27]  E. Stone.  Leber congenital amaurosis - a model for efficient genetic testing of heterogeneous disorders: LXIV Edward Jackson Memorial Lecture. , 2007, American journal of ophthalmology.

[28]  G. Fishman,et al.  The natural history of stargardt disease with specific sequence mutation in the ABCA4 gene. , 2009, Investigative ophthalmology & visual science.

[29]  Michael Bach,et al.  ISCEV Standard for full-field clinical electroretinography (2015 update) , 2014, Documenta Ophthalmologica.

[30]  Adam P. DeLuca,et al.  Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease , 2013, Human molecular genetics.

[31]  Bradley P. Coe,et al.  Copy number variation detection and genotyping from exome sequence data , 2012, Genome research.

[32]  Kathleen A. Marshall,et al.  Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[33]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[34]  Y. Shugart,et al.  Mutations in the RPGR gene cause X-linked cone dystrophy. , 2002, Human Molecular Genetics.

[35]  T. Dryja,et al.  Dominant and digenic mutations in the peripherin/RDS and ROM1 genes in retinitis pigmentosa. , 1997, Investigative ophthalmology & visual science.

[36]  V. Sheffield,et al.  Deducing the pathogenic contribution of recessive ABCA4 alleles in an outbred population , 2010, Human molecular genetics.

[37]  J. Kidd,et al.  Discovery and characterization of Alu repeat sequences via precise local read assembly , 2015, bioRxiv.

[38]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[39]  T. Braun,et al.  Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa , 2013, eLife.

[40]  Shahbaz Ali,et al.  Splice-site mutations identified in PDE6A responsible for retinitis pigmentosa in consanguineous Pakistani families , 2015, Molecular vision.

[41]  D. Turnbull,et al.  Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. , 1991, American journal of human genetics.

[42]  Naomichi Matsumoto,et al.  Precise detection of chromosomal translocation or inversion breakpoints by whole-genome sequencing , 2014, Journal of Human Genetics.

[43]  J. Toppari,et al.  Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene , 2016, Scientific Reports.

[44]  E. Stone,et al.  Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial. , 2015, Translational research : the journal of laboratory and clinical medicine.

[45]  E. Stone,et al.  The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis. , 2011, Investigative ophthalmology & visual science.

[46]  M. Michaelides,et al.  Investigation of Aberrant Splicing Induced by AIPL1 Variations as a Cause of Leber Congenital Amaurosis. , 2015, Investigative ophthalmology & visual science.

[47]  T. Dryja,et al.  Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. , 1994, Science.

[48]  P. Sieving,et al.  X-linked recessive atrophic macular degeneration from RPGR mutation. , 2002, Genomics.